"I may have been swayed if this represented a major advance in the field," said panelist Walter Dunn, MD, PhD, of the ...

The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's antipsychotic drug in combination with Viatris' antidepressant Zoloft for ...

A controversial treatment offers a painless route to ridding veterans of their trauma responses. But does it really work?

Present-centered therapy (PCT) is a non-trauma, manualized psychotherapy for adults with post-traumatic stress disorder (PTSD). PCT was originally designed as a treatment comparator in trials ...

A boy charged with manslaughter and other crimes after accidentally shooting and killing his 15-year-old cousin will no ...

FDA reviewers flag "discordant results" in a briefing document published ahead of Friday's advisory committee meeting for the ...

Data suggest that OSA diagnoses were associated with an increased risk for physical and psychological problems in active-duty ...

The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with post-traumatic stress disorder (PTSD) ...

Otsuka Pharma (OTCPK:OTSKY) and H. Lundbeck (OTCPK:HLBBF) draws efficacy concerns for their PTSD therapy from the FDA ahead ...

The Center of Family Services of Palm Beach County is the only facility in the area providing "Reconsolidation of Traumatic Memories" (RTM) therapy, which is transforming the lives of those living ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).

University of Leeds psychologists report that stress appraisal and perceived stress act as key conduits linking childhood ...